25 weeks for Assay Results, Board Change?

It has been 18 weeks since the 6th of April and now management ask to wait for another 7 weeks.
25 weeks will pass to receive data, half a year of "Tick Tock" 13th of February 2017 Bit225-009 trial started. 18 months since we started and we will be at 20 months at end of September 2018. Far cry from Preliminary Results 3rd Quarter 2017.

We already have 15% of SH's signed up and potential board members for election, if we can get 50% of SH votes there is potential sweeping change of the Board if right people are available.

Email to the below address to register Name of Holding's and Holding's Amount in Ordinary Shares.

Also add your preference to:

1. Remove chairman and directors.
2. Appoint additional director.
3. Oppose at the next AGM re-election of standing director and motion to appoint new director.

[email protected]

Candidates for chairman and directors will be communicated via email prior to formal petition request to the company for a EGM.

Keep in mind - 13th Feb 2017 Ann
The commencement of the BIT225-009 clinical trial builds on the recent announcement by Biotron of
successful results with BIT225 in a humanised mouse study of HIV-1 infection.
Biotron’s Managing Director, Dr. Michelle Miller said, “Initiating this clinical trial is an important
step towards demonstrating the clinical benefit that BIT225 could bring to the treatment of HIV-1.
BIT225 has the potential to play a key role in the eradication of HIV-1 by targeting and clearing HIV-
1 from cellular reservoirs. We expect to see early results from the trial in late Q3 this year.”